Published in PLoS One on October 28, 2011
Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat Rev Immunol (2013) 1.77
Reproductive history and breast cancer risk. Breast Cancer (2012) 1.14
TIMPs: versatile extracellular regulators in cancer. Nat Rev Cancer (2016) 0.79
Bidirectional psychoneuroimmune interactions in the early postpartum period influence risk of postpartum depression. Brain Behav Immun (2015) 0.78
Timp3 deficient mice show resistance to developing breast cancer. PLoS One (2015) 0.75
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell (1997) 24.57
Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell (1996) 16.73
The pathophysiology of mitochondrial cell death. Science (2004) 13.87
Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell (1997) 12.83
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med (2001) 9.99
Inhibition of adipogenesis by Wnt signaling. Science (2000) 9.72
Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity (1998) 6.07
Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev (1995) 6.03
Stromal effects on mammary gland development and breast cancer. Science (2002) 5.22
Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol (1997) 4.22
Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol (1994) 3.68
Information networks in the mammary gland. Nat Rev Mol Cell Biol (2005) 3.57
Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci (2001) 3.51
Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol (1992) 3.29
Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol (2008) 3.29
Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res (2003) 3.13
TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett (1998) 3.04
Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet (2004) 2.96
Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev (1999) 2.91
Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development (1996) 2.88
Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol (2003) 2.68
E-cadherin is a survival factor for the lactating mouse mammary gland. Mech Dev (2002) 2.63
Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer (2006) 2.52
Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res (2003) 2.48
Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res (2003) 2.29
Stromelysin-1 regulates adipogenesis during mammary gland involution. J Cell Biol (2001) 2.03
Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Differ (2005) 1.93
Cleavage and shedding of E-cadherin after induction of apoptosis. J Biol Chem (2000) 1.90
Ectodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in mice. J Clin Invest (2010) 1.75
Human breast development. J Mammary Gland Biol Neoplasia (2000) 1.71
Accelerated apoptosis in the Timp-3-deficient mammary gland. J Clin Invest (2001) 1.71
Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution. Development (2000) 1.70
Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol (2010) 1.65
Timp-1 is important for epithelial proliferation and branching morphogenesis during mouse mammary development. Dev Biol (1999) 1.63
Generation and characterization of Smac/DIABLO-deficient mice. Mol Cell Biol (2002) 1.61
Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia (2009) 1.55
Mfge8 is critical for mammary gland remodeling during involution. Mol Biol Cell (2005) 1.53
Involution: apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ. Breast Cancer Res (2006) 1.51
Impaired involution of mammary glands in the absence of milk fat globule EGF factor 8. Proc Natl Acad Sci U S A (2005) 1.48
Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation. J Immunol (2006) 1.45
Deletion of Stat3 blocks mammary gland involution and extends functional competence of the secretory epithelium in the absence of lactogenic stimuli. Endocrinology (2002) 1.40
Individual Timp deficiencies differentially impact pro-MMP-2 activation. J Biol Chem (2006) 1.34
Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution. J Biol Chem (2000) 1.26
Mammary gland involution as a multi-step process. J Mammary Gland Biol Neoplasia (2007) 1.23
Tissue involution and the acute phase response. Ann N Y Acad Sci (2003) 1.21
Leukemia inhibitory factor induces apoptosis of the mammary epithelial cells and participates in mouse mammary gland involution. Exp Cell Res (2003) 1.20
Do inflammatory cells participate in mammary gland involution? J Mammary Gland Biol Neoplasia (2002) 1.20
Roles of Fas and Fas ligand during mammary gland remodeling. J Clin Invest (2000) 1.18
Apoptosis regulation in the mammary gland. Cell Mol Life Sci (2004) 1.16
Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation. BMC Dev Biol (2010) 1.11
Full-length and N-TIMP-3 display equal inhibitory activities toward TNF-alpha convertase. Biochem Biophys Res Commun (2001) 1.06
TIMP3 checks inflammation. Nat Genet (2004) 1.06
Loss of interleukin 6 results in delayed mammary gland involution: a possible role for mitogen-activated protein kinase and not signal transducer and activator of transcription 3. Mol Endocrinol (2002) 1.03
Pregnancy and post-partum breast cancer: a prospective study. Anticancer Res (2008) 1.01
Enhanced metastatic dissemination to multiple organs by melanoma and lymphoma cells in timp-3-/- mice. Oncogene (2006) 1.00
Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis. Am J Pathol (2005) 0.98
Tumor necrosis factor-alpha: a multifunctional regulator of mammary gland development. Endocrinology (1996) 0.96
That impish TIMP: the tissue inhibitor of metalloproteinases-3. J Clin Invest (2001) 0.96
Mammary gland reprogramming: metalloproteinases couple form with function. Cold Spring Harb Perspect Biol (2011) 0.93
Immune cell regulators in mouse mammary development and involution. J Anim Sci (2008) 0.93
Ultrastructural and biochemical observations on the early changes in apoptotic epithelial cells of the rat prostate induced by castration. Cell Tissue Res (1999) 0.86
Mouse mammary gland involution is associated with cytochrome c release and caspase activation. Mech Dev (2001) 0.82
The importance of macrophages in the removal of fat from the involuting mammary gland. Res Vet Sci (1969) 0.82
Leucocyte phenotypes in involuting and fully involuted mammary glandular tissues and secretions of sheep. J Anat (2000) 0.82
Involvement of growth factors in thymic involution. Microsc Res Tech (2003) 0.81
Bovine leukocytes in mammary secretions during involution: surface protein changes. Am J Vet Res (1986) 0.76
A study of bovine T-cell subsets in the blood and mammary gland secretions during the dry period. Vet Immunol Immunopathol (1986) 0.76
Regulation of cancer cell migration and bone metastasis by RANKL. Nature (2006) 5.27
Progesterone induces adult mammary stem cell expansion. Nature (2010) 4.69
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature (2010) 4.01
Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet (2004) 2.96
The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.71
RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev (2005) 2.59
iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science (2012) 2.14
Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J Cell Biol (2003) 2.12
Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation (2007) 2.03
Involvement of mammalian Mus81 in genome integrity and tumor suppression. Science (2004) 2.03
Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3. Cardiovasc Res (2005) 1.77
Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. J Clin Invest (2005) 1.76
Ectodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in mice. J Clin Invest (2010) 1.75
Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis. Immunity (2012) 1.75
ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site. J Cell Sci (2010) 1.49
Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation. J Immunol (2006) 1.45
Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc Res (2007) 1.40
Circulating hormones and estrous stage predict cellular and stromal remodeling in murine uterus. Reproduction (2007) 1.37
TIMP-3 deficiency leads to dilated cardiomyopathy. Circulation (2004) 1.36
Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. Gastroenterology (2008) 1.36
Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol (2006) 1.35
Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice. J Clin Invest (2010) 1.35
Individual Timp deficiencies differentially impact pro-MMP-2 activation. J Biol Chem (2006) 1.34
Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases. FASEB J (2008) 1.32
Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology (2005) 1.31
BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival. J Exp Med (2013) 1.30
The role of tissue inhibitors of metalloproteinases in tumorigenesis and metastasis. Crit Rev Clin Lab Sci (2008) 1.28
Clipping, shedding and RIPping keep immunity on cue. Trends Immunol (2008) 1.20
Transgenic overexpression of IGF-II induces spontaneous lung tumors: a model for human lung adenocarcinoma. Oncogene (2003) 1.20
Collaboration of Brca1 and Chk2 in tumorigenesis. Genes Dev (2004) 1.18
Increased collagen and aggrecan degradation with age in the joints of Timp3(-/-) mice. Arthritis Rheum (2007) 1.16
Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. J Cell Sci (2012) 1.13
Myocardial extra-cellular matrix and its regulation by metalloproteinases and their inhibitors. Thromb Haemost (2005) 1.12
Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells. Development (2013) 1.11
Simultaneous transforming growth factor beta-tumor necrosis factor activation and cross-talk cause aberrant remodeling response and myocardial fibrosis in Timp3-deficient heart. J Biol Chem (2009) 1.10
Tissue inhibitor of metalloproteinases 3 regulates resolution of inflammation following acute lung injury. Am J Pathol (2009) 1.10
Thinking outside the cell: proteases regulate hepatocyte division. Trends Cell Biol (2005) 1.08
A null mutation for tissue inhibitor of metalloproteinases-3 (Timp-3) impairs murine bronchiole branching morphogenesis. Dev Biol (2003) 1.04
Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice. Hepatology (2010) 1.03
Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model. Cancer Res (2002) 1.02
Mice with tissue inhibitor of metalloproteinases 4 (Timp4) deletion succumb to induced myocardial infarction but not to cardiac pressure overload. J Biol Chem (2010) 1.02
Inflammation and breast cancer: metalloproteinases as common effectors of inflammation and extracellular matrix breakdown in breast cancer. Breast Cancer Res (2008) 0.99
Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis. Am J Pathol (2005) 0.98
Insulin-like growth factor-II regulates PTEN expression in the mammary gland. J Biol Chem (2003) 0.98
TIMP-3 recruits quiescent hematopoietic stem cells into active cell cycle and expands multipotent progenitor pool. Blood (2010) 0.97
Cbl-3-deficient mice exhibit normal epithelial development. Mol Cell Biol (2003) 0.95
Proteolytic factors in exosomes. Proteomics (2013) 0.90
Unraveling metalloproteinase function in skeletal biology and disease using genetically altered mice. Biochim Biophys Acta (2009) 0.90
Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay. EMBO Mol Med (2013) 0.85
Neither ovariectomy nor progestin treatment prevents endometrial neoplasia in pten+/- mice. Gynecol Oncol (2007) 0.85
Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis. J Gene Med (2004) 0.85
Proteolysis during tumor cell extravasation in vitro: metalloproteinase involvement across tumor cell types. PLoS One (2013) 0.85
Metalloproteinase axes increase beta-catenin signaling in primary mouse mammary epithelial cells lacking TIMP3. J Cell Sci (2007) 0.85
Active allies: hormones, stem cells and the niche in adult mammopoiesis. Trends Endocrinol Metab (2012) 0.85
Increased neovascularization in mice lacking tissue inhibitor of metalloproteinases-3. Invest Ophthalmol Vis Sci (2011) 0.84
Matrix metalloproteinase activity modulates tumor size, cell motility, and cell invasiveness in murine aggressive fibromatosis. Cancer Res (2004) 0.84
Stromal TIMP3 regulates liver lymphocyte populations and provides protection against Th1 T cell-driven autoimmune hepatitis. J Immunol (2012) 0.82
Localized interleukin-12 delivery for immunotherapy of solid tumours. J Cell Mol Med (2013) 0.81
High CD49f expression is associated with osteosarcoma tumor progression: a study using patient-derived primary cell cultures. Cancer Med (2014) 0.78
Intravitreal injection of TIMP3 or the EGFR inhibitor erlotinib offers protection from oxygen-induced retinopathy in mice. Invest Ophthalmol Vis Sci (2013) 0.78
Experimental manipulation of radiographic density in mouse mammary gland. Breast Cancer Res (2004) 0.76
The mammary stem cell conundrum: is it unipotent or multipotent? Breast Cancer Res (2012) 0.75